Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer

BACKGROUND: For patients receiving add-on Viscum album L. (VA) treatments for late-stage pancreatic cancer, an improved overall survival (OS) was observed. Only limited information regarding cost-effectiveness (CE) for comparisons between standard of care and standard of care plus add-on VA in stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Thronicke, Anja, Reinhold, Thomas, von Trott, Philipp, Matthes, Harald, Schad, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093905/
https://www.ncbi.nlm.nih.gov/pubmed/32256640
http://dx.doi.org/10.1155/2020/3543568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093905/
https://www.ncbi.nlm.nih.gov/pubmed/32256640
http://dx.doi.org/10.1155/2020/3543568

Ejemplares similares